Chapter 16. Advances in Nucleoside and Nucleotide Antiviral Therapies

Annual Reports in Medicinal Chemistry

Volumn 33, Issue C, 1998, Pages 163-171

  Koszalka, George W ^a   Daluge, Susan M ^a   Boyd, F Leslie ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001935774     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-7743(08)61081-7     Document Type: Chapter

References (74)

1. Mansour T.S., and Storer R. Current Pharm. Design 3 (1997) 227
2. Herdewijn P. Drug Discovery Today 2 (1997) 235
3. Mansour T. Exp. Opin.Ther. Patents 6 (1996) 37
4. Kolb V.M. In: Jucker E. (Ed). "Progress in Drug Research" 48 (1997), Birkhauser Verlag, Basel, Switzerland 195
5. Yao G.O., Liu S.-H., Chou E., Kukhanova M., Chu C.K., and Cheng Y.-C. Biochem. Pharm. 51 (1996) 941
6. Witcher J.W., Boudinot F.D., Baldwin B.H., Ascenzi M.A., Tennant B.C., Du J.F., and Chu C.K. Antimicrob. Agents Chemother. 41 (1997) 2184
7. Cheng, Y.-C., Chu, C.K., Peek, S.F., Tennant, B.C., Korba, B.E. and Boudinot, F.D., Antiviral Ther., Abstr.27, Second International Conference on Therapies for Viral Hepatitis, December(1997)
8. Zhu Y.L., Dutschman G.E., Luo M.Z., Gullen E.A., Pai S.B., Guo X., Lin T.S., and Cheng Y.-C. Proc. Am.Assoc. Cancer Res. 38 (1997) 608
9. Brown, N. and Rubin, M., Antiviral Ther., Abstr.2, Second International Conference on Therapies for Viral Hepatitis, December(1997)
10. Tennant, B.C., Peek, S.F., Toshkov, I.A., Erb, H.N., Hornbuckle, W.E., Schinazi, R.F., Korba, B.E., Cote, P.J. and Gerin, J.L., Antiviral Ther., Abstr.30, Second International Conference on Therapies for Viral Hepatitis, December(1997)
11. Richard N., Belmonte A.R., Salomon H., Nagai K., Mansour T., and Wainberg M.A. Nucleosides and Nucleotides 16 (1997) 1235
12. Fedorov I.I., Kazmina E.M., Gurskaya G.V., Jasko M.V., Zavodnic V.E., Balzarini J., De Clercq E., Faraj A., Sommadossi J.-P., Imbach J.-L., and Gosselin G. J. Med. Chem. 40 (1997) 486
13. th Conference on Retroviruses and Opportunistic Infections, Washington, D.C.(1997)
14. Furman, P.A., Szczech, G., Cleary, D.G., Korba, B., Sommadossi, J.-P. and Schinazi, R.F., Antiviral Ther., Abstr.26, Second International Conference on Therapies for Viral Hepatitis, December(1997)
15. Gosselin G., Boudou V., Griffon J.-F., Pavia G., Pierra C., Imbach J.-L., Aubertin A.-M., Schinazi R.F., Faraj A., and Sommadossi J.-P. Nucleosides and Nucleotides 16 (1997) 1389
16. Kotra L.P., Xiang Y., Newton M.G., Schinazi R.F., Cheng Y.-C., and Chu C.K. J. Med. Chem. 40 (1997) 3635
17. Ma T., Lin J.-S., Newton M.G., Cheng Y.-C., and Chu C.K. J. Med. Chem. 40 (1997) 2750
18. Van Draanen N.A., Freeman G.A., Short S.A., Harvey R.J., Jansen R., Szczech G., and Koszalka G.W. J. Med. Chem. 39 (1996) 538
19. Rahim S.G., Trivedi N., Bougnovic-Batchelor M.V., Hardy G.W., Mills G., Selway J.T., Snowden W., Littler E., Coe P.L., Basnak I., Whale R.F., and Walker R.T. J. Med. Chem. 39 (1996) 789
20. Basnak I., Sun M., Coe P.L., and Walker R.T. Nucleosides and Nucleotides 15 (1996) 121
21. Selwood D.L., Carter K., Young R.J., and Jandu K.S. Bioorg. Med.Chem. Lett. 6 (1996) 991
22. Yoshimura Y., Watanabe M., Satoh H., Ashida N., Ijichi K., Sakata S., Machida H., and Matsuda A. J. Med. Chem. 40 (1997) 2177
23. Machida, H., Ashida, N., Miura, S., Watanabe, M., Yamada, K., Kitano, K. and Yoshimura, Y., Tenth International Conference on Antiviral Research, Abstr. 120, April(1997)
24. Freeman S., and Gardinier J.M. Molecular Biotechnology 5 (1996) 125
25. Naesens L., Snoeck R., Adrei G., Balzarini J., Neyts J., and De Clerq E. Antiviral Chem. Chemother. 8 (1997) 1
26. Barnard D.L., Bischofberger N., Kim C.U., Huffman J.H., Sidwell R.W., Dougherty J.P., Lew W., Williams M.A., and Yang W. Antiviral Chem. Chemother. 8 (1997) 223
27. Ives D.V. AIDS 11 (1997) 1791
28. th ICAAC, Sept.28-Oct.1, Toronto, Ontario, Abstr.H62(1997)
29. th ICAAC, Sept.28-Oct. 1, Toronto, Ontario, Abstr.H62(1997)
30. Shaw, T., Colledge, D. and Locarnini, S.A., Tenth International Conference on Antiviral Research, Abstr.33, April(1997)
31. Korba, B.E., Baldwin, B., Cote, P., Schinazi, R., Gangemi, D., Gerin, J.L. and Tennant, B.C., Tenth International Conference on Antiviral Research, Abstr.37, April(1997)
32. Zemlicka J. International Antiviral News 5 (1997) 51
33. Qui Y.L., Ksebati M.B., Ptak R.G., Fan B.Y., Breitenbach J.M., Lin J., Cheng Y., Kern E.R., Drach J.C., and Zemlicka J. J. Med. Chem. 41 (1998) 10
34. th ICAAC, Sept.28-Oct.1, Toronto, Ontario, Abstr.H49(1997)
35. Arimilli M.N., Kim C.U., Dougherty J., Mulato A., Oliyai R., Shaw J.P., Cundy K.C., and Bischofberger N. Antiviral Chem. Chemother. 8 (1997) 557
36. Jones R.J., and Bischofberger N. Antiviral Res. 27 (1997) 1
37. McGuigan C., Camarasa M.-J., Egberink H., Hartmann K., Karlsson A., Perno C.-F., and Balzarini J. Internatl. Antiviral News 5 (1997) 19
38. McGuigan C., Cahard D., Salgado A., Bidois L., Velazquez S., Yarnold C.J., Turner K., Sutton P., Wedgewood O., Tsang H.-W., Turner S.J., Wang Y., O'Leary G., Mahmood N., Hay A., and Balzarini J. In: Bentley H., and O'Hanlon P.J. (Eds). "Anti-infectives: Recent Advances in Chemistry and Structure-Activity Relationships" (1997), The Royal Society of Chemistry 251
39. Perigaud C., Girardet J.-L., Gosselin G., and Imbach J.-L. In: De Clercq E. (Ed). "Advances in Antiviral Drug Design" 2 (1996), JAI Press Inc., Greenwich, Conn. 147
40. Gosselin G., Girardet J.-L., Perigaud C., Benzaria S., Lefebvre I., Schlienger N., Pompon A., and Imbach J.-L. Acta Biochimica Polonica 43 (1996) 195
41. Meier C., Knispel T., Lorey M., and Balzarini J. Internatl. Antiviral News 5 (1997) 183
42. Balzarini J., Karlsson A., Aquaro S., Perno C.F., Cahard D., Naesens L., De Clercq E., and McGuigan C. Proc. Natl.Acad. Sci.USA 93 (1996) 7295
43. Balzarini J., Egberink H., Hartmann K., Cahard D., Vahlenkamp T., Thormar H., De Clercq E., and McGuigan C. Molec. Pharmacol. 50 (1996) 1207
44. McGuigan C., Salgado A., Yarnold C., Harries T.Y., De Clercq E., and Balzarini J. Antiviral Chem. Chemother. 7 (1996) 184
45. McGuigan C., Tsang H.-W., Cahard D., Turner K., Velazquez S., Salgado A., Bidois L., Naesens L., De Clercq E., and Balzarini J. Antiviral Res. 35 (1997) 195
46. McGuigan C., Cahard D., Sheeka H.M., De Clercq E., and Balzarini J. J. Med. Chem. 39 (1996) 1748
47. McGuigan C., Wedgwood O.M., De Clercq E., and Balzarini J. Bioorg. and Med. Chem.Lett. 6 (1996) 2359
48. Balzarini J., Kruining J., Wedgwood O., Pannecouque C., Aquaro S., Perno C.-F., Naesens L., Witvrouw M., Heijtink R., De Clercq E., and McGuigan C. FEBS Lett. 410 (1997) 324
49. McIntee E.J., Remmel R.P., Schinazi R.F., Abraham T.W., and Wagner C.R. J. Med. Chem. 40 (1997) 3323
50. Valette G., Pompon A., Girardet J.-L., Cappellacci L., Franchetti P., Grifantini M., La Colla P., Loi A.G., Perigaud C., Gosselin G., and Imbach J.-L. J. Med. Chem. 39 (1996) 1981
51. Benzaria S., Pelicano H., Johnson R., Maury G., Imbach J.-L., Aubertin A.-M., Obert G., and Gosselin G. J. Med. Chem. 39 (1996) 4958
52. Perigaud C., Girardet J.-L., Lefebvre I., Xie M.-Y., Aubertin A.-M., Kirn A., Gosselin G., Imbach J.-L., and Sommadossi J.-P. Antiviral Chem. Chemother 7 (1996) 338
53. Perigaud C., Gosselin G., and Imbach J.-L. Antiviral Ther. 1 Suppl. 4 (1997) 39
54. Gosselin, G. and Imbach., J.-L. U.S. Patent 5,627,185(1997)
55. Imbach, J.-L., Gosselin, G., Mathe, C., Pierre, C., Boudou, V., Faraj, A., Loi, A.G., Cretton-Scott, E., Placidi, L., Schinazi, R.F., Locarnini, S., Korba, B., Tennant, W. and Sommadossi, J.-P., Abstr.25, Second International Conference on Therapies for Viral Hepatitis, Hawaii, December15-19 (1997)
56. Meier C., Lorey M., De Clercq E., and Balzarini J. Bioorg. Med. Chem. Lett. 7 (1997) 99
57. Meier C., Knispel T., De Clercq E., and Balzarini J. Bioorg. Med.Chem. Lett. 7 (1997) 1577
58. Hostetler K.Y., Beadle J.R., Kini G.D., Gardner M.F., Wright K.N., Wu T.-H., and Korba B.A. Biochem. Pharmacol. 53 (1997) 1815
59. Tsotinis A., Calogeropoulou T., Koufaki M., Souli C., Balzarini J., De Clercq E., and Makriyannis A. J. Med. Chem. 39 (1996) 3418
60. Hong C.I., Nechaev A., Kirisits A.J., Vig R., West C.R., Manouilov K.K., and Chu C.K. J. Med. Chem. 39 (1996) 1771
61. Tse H.L.A., Knight D.J., Coates J.A.V., and Mansour T.S. Biorg. Med.Chem. Lett. 7 (1997) 1387
62. Marquez V.E. In: De Clercq E. (Ed). Advances "Antiviral Drug Design" 2 (1996), JAI Press Inc., Greenwich, Conn. 89
63. Innaimo S.F., Seifer M., Bisacchie G.S., Standring D.N., Zahler R., and Colonno R.J. Antimicrob. Agents Chemother. 41 (1997) 1444
64. Bisacchi G.S., Chao S.T., Bachard C., Daris J.P., Innaimo S., Jacobs G.A., Kocy O., Lapointe P., Martel A., Merchant Z., Slusarchyk W.A., Sundeen J.E., Young M.G., Colonno R., and Zahler R. Bioorg. Med.Chem. Lett. 7 (1997) 127
65. Tenney D.J., Yamanaka G., Voss S.M., Cianci C.W., Tuomari A.V., Schaeffer A.K., Alam M., and Colonno R.J. Antimicrob. Agents Chemother. 41 (1997) 2680
66. DeHertogh, D., Colonno, R. and Grasela, D., Abstr.1, Second International Conference on Therapies for Viral Hepatitis, Hawaii, December15-19(1997)
67. th ICAAC, Sept. 28-Oct.1, Toronto, Ontario, Abstr.H46a(1997)
68. th ICAAC, Oct.4-7, Orlando, Abstr.I6; M. Tisdale, N.R. Parry, D. Cousens, M.H. St. Clair, and L.R. Boone, ibid. Abstr.I82; M.B. Faletto, W.H. Miller, E.P. Garvey, J.E. Reardon, and S.S. Good, ibid., Abstr.I84; S.S. Good, B.S. Owens, M.B. Faletto, W.B. Mahony, and B.A. Domin, ibid., Abstr.I86; S.V. Ching, K.M. Ayers, R.E. Dornsife, D. Lewis, G.L. Grebe, and J.L. Howard, ibid., Abstr.I88(1994)
69. Saag, M., Abstracts from the 3rd Conference on Retroviruses and Opportunistic Infections, Abstr.195 1996; G. Torres, GMHC Treatment Issues, 10, 8, 1996
70. Daluge S.M., Good S.S., Faletto M.B., Miller W.H., Clair M.H.St., Boone L.R., Tisdale M., Parry N.R., Reardon J.E., Dornsife R.E., Averett D.R., and Krenitsky T.A. Antimicrob. Agents Chemother. 41 (1997) 1082
71. Tisdale M., Alnadaf T., and Cousens D. Antimicrob. Agents Chemother. 41 (1997) 1094
72. Faletto M.B., Miller W.H., Garvey E.P., Clair M.H.St., Daluge S.M., and Good S.S. Antimicrob. Agents Chemother. 41 (1997) 1099
73. Shuto S., Obara T., Saito Y., Yamashita K., Tanaka M., Sasaki T., Andrei G., Snoeck R., Neyts J., Padalko E., Balzarini J., De Clercq E., and Matsuda A. Chem. Pharm.Bull. 45 (1997) 1163
74. Obara T., Shuto S., Saito Y., Snoeck R., Andrei G., Balzarini J., De Clercq E., and Matsuda A. J. Med. Chem. 39 (1996) 3847